The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $51.90

Today's change+0.55 +1.07%
Updated November 28 9:47 AM EST. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $51.90

Today's change+0.55 +1.07%
Updated November 28 9:47 AM EST. Delayed by at least 15 minutes.

DexCom Inc up (U.S.)$0.55

DexCom Inc is up today by (U.S.)$0.55 or 1.07% to (U.S.)$51.90. Over the last five days, shares have gained 3.04% and are currently 4.77% off of the 52-week high. Shares have outperformed the S&P 500 by 41.40% during the last year.

Key company metrics

  • Open(U.S.) $51.68
  • Previous close(U.S.) $51.35
  • High(U.S.) $52.17
  • Low(U.S.) $51.60
  • Bid / Ask(U.S.) $51.87 / (U.S.) $51.94
  • YTD % change+46.57%
  • Volume30,303
  • Average volume (10-day)594,718
  • Average volume (1-month)748,391
  • Average volume (3-month)639,488
  • 52-week range(U.S.) $28.09 to (U.S.) $54.50
  • Beta0.43
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.36
Updated November 28 9:47 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-11.61%

DexCom Inc has a net profit margin of -11.61%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.62%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue69594752
Total other revenue--------
Total revenue69594752
Gross profit47403034
Total cost of revenue22191718
Total operating expense74655954
Selling / general / administrative34312824
Research & development19151513
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-6-12-2
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-6-13-3
Income after tax-5-6-13-3
Income tax, total0000
Net income-5-6-13-3
Total adjustments to net income--------
Net income before extra. items-5-6-13-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-6-13-3
Inc. avail. to common incl. extra. items-5-6-13-3
Diluted net income-5-6-13-3
Dilution adjustment0000
Diluted weighted average shares76757372
Diluted EPS excluding extraordinary itemsvalue per share-0.07-0.08-0.17-0.04
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.07-0.08-0.17-0.04